Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 283 clinical trials
Fatty Liver and Ectopic Fat in Overweight and Obese Patients

The aim of the study is to find new clinico-biological and medical imaging parameters associated with non alcoholic steatohepatitis in overweight and obese patients.

  • 2 views
  • 07 Nov, 2020
  • 1 location
Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)

The purpose of this study is to examine the effect of metformin on biochemical and histological findings in NAFLD patients with insulin resistance syndrome.

diabetes
insulin
fatty liver
  • 8 views
  • 07 Nov, 2020
  • 1 location
A Phase 2b Study of Icosabutate in Fatty Liver Disease

A Phase 2b study to evaluate the efficacy of different doses of NST-4016 on the resolution of NASH without worsening of fibrosis

  • 291 views
  • 28 Jan, 2021
  • 40 locations
Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management

Some studies have shown beneficial results with probiotics on hepatic function of subjects with fatty liver, but significant variability has been noted among probiotic formulations. This study

  • 0 views
  • 07 Apr, 2021
  • 1 location
Lifestyle Modification for MAFLD Based on TTM

Lifestyle changes aiming at weight loss remain the cornerstone of MAFLD treatment.Evaluating the motivational stage of patients' change and providing targeted lifestyle guidance may significantly improve the efficiency of weight loss. The investigators hypothesize that gut microbiota may affect motivation to lose weight, and the changes in gut microbiota due …

  • 0 views
  • 09 May, 2021
  • 1 location
Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients

non-alcoholic hepatic steatosis and steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD). Recent data support the activation of the farnesoid X receptor (FXR, NR1H4), a nuclear hormone

  • 2 views
  • 26 Jan, 2021
  • 2 locations
Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference

). Even if the liver fibrosis is the key pathological feature of progressive liver disease, the accumulation of excessive hepatic triglyceride, hepatic steatosis, is today recognized as an

hepatitis
fibrosis
steatosis
hepatic fibrosis
fatty liver
  • 0 views
  • 30 Jan, 2021
  • 8 locations
Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I

; and the prevention of increased liver steatosis based on ultrasound with elastography.

  • 33 views
  • 29 Apr, 2021
  • 1 location
Assessment of the Correlation Between Serum Levels of Adropin and Degree of Severity of Chronic Liver Disease

commonly used methods is perfect. In one meta-analysis, different methods were compared for diagnosis of cirrhosis in Non-alcoholic fatty liver disease (NAFLD) patients. For example (sensitivity

  • 0 views
  • 27 Jan, 2021
  • 1 location
Effect of a Three Combined Probiotics Supplementation on Weight Loss in Obese/Overweight Children

This program is a double-blind, randomized, placebo-controlled study. Investigators expect to enroll 100 overweight or obese children those ages 6 to 18 years. A product that containing three probiotics will be prescribed for study group for 12 weeks plus diet and exercise guidance, while the control group will be given …

  • 0 views
  • 22 Jan, 2021
  • 1 location